Abstract
Cyclobenzaprine is commonly used as a muscle relaxant and analgesic. Given its tricyclic properties, serotonin syndrome is a potential side effect of this drug. We report an unusual case of a patient who experienced symptoms of delirium and hyperkinetic movement disorders shortly after initiating treatment with cyclobenzaprine and oxycodone. Symptoms resolved within 48 h of discontinuing cyclobenzaprine. This case serves to remind clinicians to monitor for serotonin syndrome when initiating cyclobenzaprine, and when adding opiate or antidepressant medications to the regimen. Copyright 2013 BMJ Publishing Group. All rights reserved.
Cite
CITATION STYLE
Shprecher, D., Sloan, C. T., & Sederholm, B. (2013). Neuropsychiatric side effects of cyclobenzaprine. BMJ Case Reports. https://doi.org/10.1136/bcr-2013-008997
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.